Building a 100-billion-level strategic emerging industrial cluster - a review of the high-quality development achievements of the city's biomedicine and life and health industries

In Changchun Baike Biotechnology Co., Ltd., the production workshop is busy, the intelligent assembly line production equipment is running efficiently, the employees are full of energy, busy production, catching up with orders, rushing to progress, and the laboratory staff is carrying out relevant testing...... The enterprise is full of surging power for jointing upward. In June last year, the company's new product, live attenuated herpes zoster vaccine, was officially launched, which is the world's first live attenuated herpes zoster vaccine for people over 40 years old, marking a breakthrough in the mainland to achieve zero domestic herpes zoster vaccine. "Work hard!" said the relevant person in charge of Changchun Baike Biotechnology Co., Ltd., on the basis of a new high in performance in 2023, in the first quarter of this year, the output value of Baike Biotechnology reached 650 million yuan, and it will continue to maintain a positive growth trend, and continue to enhance the competitiveness of enterprises around the innovative research and development of human vaccines.

This is a vivid portrayal of the high-quality development of the city's biomedicine and life and health industries.

As one of the "top 4" main track industries determined by the city's future development, the biomedicine and life and health industry is not only a "sunrise industry that never ends", but also the most growing, leading and breakthrough key development direction in the future, and has become a breakthrough in the optimization and upgrading of the city's industrial structure, a new engine for economic development, and a new driving force for cultivating and developing new quality productivity.

In 2023, the city's biomedicine and life and health industries will complete an output value of 97.8 billion yuan.

High-quality development has "strength"

In Changchun, the old industrial base in Northeast China, the construction of a 100-billion-level industrial cluster is accelerating, demonstrating the confidence and ambition of a city.

Confidence and ambition come from strength.

-- Good foundation for industrial development. Our city is one of the first three bio-industry bases recognized by the country, and the level of biopharmaceuticals is in a leading position in the country, and it has successively created the first interferon, the first industrial hepatitis B genetic engineering vaccine, the first recombinant human growth hormone, the first polylactic acid bone nail, the first automatic biochemical analyzer and many other "No. 1" in the field of national medicine and health, and has built the largest vaccine and cytokine product production base in Asia and the largest gene drug production base in China.

——The strength of leading enterprises is strong. Industrial development is inseparable from the support of the "leader". In 2023, the number of industrial enterprises above designated size included in the statistics in the biomedical field in our city will be 65. Jinsai Pharmaceutical has become the first pharmaceutical enterprise in the city with an output value of more than 10 billion yuan, and has emerged 1 billion pharmaceutical enterprises such as Modified High-tech Pharmaceutical, Baike Biotechnology, Qijian Biotechnology, Dirui Medical, and Shengboma Biotechnology, and cultivated leading enterprises in domestic subdivided fields such as Zhuoyi Biotechnology, Wu Taigankang, Boxun Biotechnology, Dentec Dental and Keying Laser. Under the leadership of leading enterprises, the foundation of the city's biomedicine and life and health industry has been increasingly consolidated, and more new formats, new technologies and new platforms have been nurtured and grown, and they have innovated and developed, transformed and upgraded in the continuous cultivation of the industrial ecology.

-- The construction of major projects is busy. The Kinsey Pharmaceutical International Industrial Park project is progressing smoothly. After the project is fully put into production, it can meet the industrial production of more than 20 new products such as Kinsey children's health, women's health, and tumors, providing strong support for the diversified development of enterprises, and at the same time, providing momentum for the high-quality development of biomedicine and life and health industries in our city.

The Beijing Medicine Traditional Chinese Medicine Culture and Health Valley project has fully resumed work. The project is divided into three phases of development and construction, mainly including five functional areas: traditional Chinese medicine industry cluster, traditional Chinese medicine health and leisure area, medical forest park experience area, understory medicinal material planting science popularization area, and rural cultural tourism and health care area. After the project is put into operation, the annual production capacity can reach 15,000 tons, and the average annual sales revenue can reach 1 billion yuan.

Nowadays, in Changchun, high-end, high value-added and high-tech projects are stepping up planning and construction, which not only brings the current development quality and speed to Changchun, but also reserves the future development potential.

High-quality development has "vitality"

Alphamab Oncology is the first high-tech and innovative biopharmaceutical enterprise specializing in the R&D and production of monoclonal antibody drugs and recombinant protein drugs in our province, and has the only provincial antibody biological drug pilot center in the province; Dirui Medical's flow cytometry microscopy technology in the field of urine analyzer and gynecological diagnosis has filled the gap in China; Boxun Biotech has become the first medical device manufacturer in China and the fourth in the world to master the micropillar gel immunodetection technology; YAG laser therapy machine is the first domestic picosecond laser treatment product approved by the State Drug Administration in mainland China......

These Changchun biomedical enterprises have an obvious feature, innovation!

Scientific and technological innovation has been integrated into the city's development genes, gathering surging momentum for the city's cultivation of new quality productivity. In the field of biomedicine and life and health, our city has innovative "national teams" such as Changchun Institute of Optics and Mechanics of the Chinese Academy of Sciences, Changchun Institute of Applied Chemistry of the Chinese Academy of Sciences, and Military Veterinary Research Institute of the Academy of Military Medical Sciences; two national key laboratories of polymer physics and chemistry of the Changchun Institute of Applied Chemistry of the Chinese Academy of Sciences and inorganic synthesis and preparative chemistry of Jilin University; a number of provincial and ministerial key laboratories such as Northeast Normal University and Changchun University of Traditional Chinese Medicine; and many academicians of medicine and health-related majors such as Xia Xianzhu, Jin Ningyi, and Chen Xuesi...... These have provided a "source of living water" for the development of biomedicine and life and health industry in our city.

Changchun, which has innovative genes, is not only seeking a single-point breakthrough in the development of biomedicine and life and health industries, but an all-round innovation and iteration of the overall industrial ecology. By improving the energy level of the science and technology innovation platform, opening up collaborative innovation channels, optimizing the innovation and entrepreneurship policy system, promoting talent entrepreneurship, scientific and technological innovation, and achievement transformation, and through the integrated development of "industry-university-research" in universities and research institutes, and establishing a collaborative innovation alliance between large enterprises, large institutes and universities, the Changchun innovation ecosystem will be more active.

High-quality development has "momentum"

The continuous optimization of the development environment will promote the accelerated release of the development potential of the city's biomedical and life and health industries.

In the development of the "hard environment", the city has four distinct seasons, moderate temperature and humidity, and the average summer temperature of about 22 degrees Celsius provides excellent climatic conditions for the development of biomedicine and life and health industries.

In terms of developing a "soft environment", the city continues to create a market-oriented, law-based and international business environment. Offline, we will continue to polish the "golden business card" of "10,000 people stationed (helping) 10,000 enterprises" to serve enterprises and help enterprises to relieve difficulties; online, we will build a solid "hard carrier" of the WeChat service group of "Changchun pro-Qing government-enterprise relationship", and build a "big platform" to boost the city's economic development through offline and online linkage. At present, the city has solved 25,957 development problems for 10,323 enterprises through the "Changchun Pro-Qing Government-Enterprise Relations" WeChat service group, and since 2023, the "10,000 people stationed (helping) 10,000 enterprises" action has efficiently solved 4,318 enterprise development problems, with a problem solving rate of 98%.

In terms of policy guarantees, the city has formulated and issued "Golden 7 Rules" to support the high-quality development of the biomedicine and life and health industries in the developed areas, and in the most critical and core areas such as supporting the construction of major projects, supporting the R&D and production of new drugs, supporting the construction of platforms, and supporting the gathering of high-end talents, with the most "three forces" (industrial support, depression effect, and project agglomeration) policy environment, "real money" provides strong development support for the majority of pharmaceutical and health enterprises and entrepreneurs to invest and develop their businesses in the long term, and become bigger and stronger.

Source: Changchun Daily